Healthcare & Life Sciences
Dyax Corp
United States
acquired
acquired
Stage
About
Dyax Corporation was a biopharmaceutical company focused on the discovery and development of therapeutic products based on human Kunitz domain protease inhibitors.
Explore Dyax Corp's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.